顺尔宁在儿童哮喘中应用【41页】

2025-12-07 999+ 2.14MB 41 页 海报
侵权投诉
白三烯受体拮抗剂 --- 孟鲁司特 ( 顺尔宁 )
在儿童哮喘治疗中的作
北京哮喘病临床研究所
Burden of Asthma in Children
~6.3 million
18 years of age
~14 million missed
school days annually
~3.5 million
physician visits*
~1/3 of pediatric
asthma deaths in
those classified
with mild asthma
~203 000
Hospitalizations*
~658 000 emergency
department visits*
*Includes 1999 or 2000 annual estimates for children <15 years of age.
American Lung Association. 2003; Mannino et al. MMWR. 2002;51:1-13.
哮喘长期控制目标 (GINA 2002)
哮喘症状得到控制
哮喘的急性发作得到预防
肺功能正常或接近正常
保持正常的体力活动 , 包括运动
避免治疗哮喘药物的副作用
预防不可逆的气道阻塞
预防因哮喘死亡

标签: #哮喘

摘要:

白三烯受体拮抗剂---孟鲁司特(顺尔宁)在儿童哮喘治疗中的作用北京哮喘病临床研究所BurdenofAsthmainChildren~6.3million18yearsofage~14millionmissedschooldaysannually~3.5millionphysicianvisits*~1/3ofpediatricasthmadeathsinthoseclassifiedwithmildasthma~203000Hospitalizations*~658000emergencydepartmentvisits**Includes1999or2000annualestimatesf...

展开>> 收起<<
顺尔宁在儿童哮喘中应用【41页】.pptx

共41页,预览13页

还剩页未读, 继续阅读

/ 41
客服
关注